International General Insurance UK CEO buys 24 shares

An ownership note says 145 unvested ESPP shares are held in an employee trust for the benefit of the CEO, IGI UK.

Rhea-AI Filing Summary

International General Insurance Holdings Ltd. CEO, IGI UK, Andreas Costas Loucaides acquired 24 common shares through the U.K. Employee Stock Purchase Plan on October 7, 2026, at $24.7867 per share. He also received an award of 24 matching common shares, eligible to vest in full on October 7, 2027, subject to continued service through that date.

Insider Trade Summary

Grant/Award: 48 shares

Grant/Award 2 txns

Insider Loucaides Andreas Costas

Role CEO, IGI UK

Type	Security	Shares	Price	Value
Grant/Award	Common Shares F1	24	$24.7867	$594.88
Grant/Award	Common Shares F2, F3	24	$0.00	$0.00

Holdings After Transaction: Common Shares — 37,980 shares (Direct)

Footnotes (3)

1. F1. Represents common shares purchased by the Reporting Person pursuant to the U.K. Employee Stock Purchase Plan (the "ESPP").
2. F2. Represents an award of matching common shares under the ESPP that will be eligible to vest in full on October 7, 2027, subject to the Reporting Person's continued service through such date.
3. F3. All of the shares reported are held directly by the Reporting Person, except for 145 of the unvested ESPP shares which are held in an employee trust for the benefit of the Reporting Person.

Key Figures

Common shares purchased: 24 shares Purchase price: $24.7867 per share Matching common shares awarded: 24 shares +1 more

4 metrics

Common shares purchased 24 shares Through the U.K. Employee Stock Purchase Plan on October 7, 2026

Purchase price $24.7867 per share U.K. Employee Stock Purchase Plan purchase on October 7, 2026

Matching common shares awarded 24 shares Awarded October 7, 2026; eligible to vest in full October 7, 2027, subject to continued service

Unvested ESPP shares held in employee trust 145 shares Held in trust for the reporting person's benefit

Key Terms

U.K. Employee Stock Purchase Plan, matching common shares, eligible to vest in full, employee trust

4 terms

U.K. Employee Stock Purchase Plan financial

"purchased by the Reporting Person pursuant to the U.K. Employee Stock Purchase Plan"

matching common shares financial

"award of matching common shares"

eligible to vest in full financial

"will be eligible to vest in full on October 7, 2027"

employee trust financial

"held in an employee trust for the benefit of the Reporting Person"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many IGIC shares did the CEO purchase and at what price?

Andreas Costas Loucaides, CEO, IGI UK, purchased 24 common shares on October 7, 2026, through the U.K. Employee Stock Purchase Plan, at $24.7867 per share. No Rule 10b5-1 plan is reported.

What matching-share award did IGIC's CEO receive?

Loucaides received an award of 24 matching common shares on October 7, 2026. The shares will be eligible to vest in full on October 7, 2027, subject to his continued service through that date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/09/2026 - 04:05 PM Accepted by SEC EDGAR 10/09/2026 - 04:05 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Loucaides Andreas Costas

(Last) (First) (Middle)

20 FENCHURCH STREET

FLOOR 15

(Street)

LONDON EC3M 3BY

(City) (State) (Zip)

UNITED KINGDOM

(Country)

2. Issuer Name and Ticker or Trading Symbol
International General Insurance Holdings Ltd. [ IGIC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO, IGI UK

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	10/07/2026		A		24(1)	A	$24.7867	37,956	D
Common Shares	10/07/2026		A		24(2)	A	$0	37,980	D(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents common shares purchased by the Reporting Person pursuant to the U.K. Employee Stock Purchase Plan (the "ESPP").

2. Represents an award of matching common shares under the ESPP that will be eligible to vest in full on October 7, 2027, subject to the Reporting Person's continued service through such date.

3. All of the shares reported are held directly by the Reporting Person, except for 145 of the unvested ESPP shares which are held in an employee trust for the benefit of the Reporting Person.

	/s/ Andreas Costas Loucaides	10/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)